Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial

Robert J. Pignolo, Geneviève Baujat, Edward C. Hsiao, Richard Keen, Amy Wilson, Jeff Packman, Andrew L. Strahs, Donna R. Grogan, Frederick S. Kaplan

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences